Cannabis Legalization: Profit Over People?

A comprehensive global review analyzing cannabis policy frameworks between 2000 and 2025 indicates that the critical question is no longer whether cannabis should be regulated, but how.

The study, published in The Lancet, found that legislation allowing cannabis sales for profit correlates with increases in use, addiction, and psychiatric hospital admissions. Conversely, decriminalization or strictly controlled legalization models did not show significant rises in cannabis use.

Researchers noted that commercialized markets, prevalent in many U.S. states and Canada, have seen increased cannabis use, higher product potency, and a rise in cannabis use disorder. This trend suggests that commercial interests may overshadow public health concerns, similar to past experiences with the alcohol and tobacco industries.

Alternative approaches, such as those adopted by Uruguay, Germany, and Malta, focus on public health, allowing limited home cultivation, non-profit cooperatives, or tightly controlled pharmacy sales. These models aim to mitigate harms while removing the negative impacts of criminalization.

While evidence outside North America is still developing, experts emphasize that the outcomes of legalization depend heavily on the regulatory model. Policymakers are urged to prioritize goals like public health, human rights, and social equity when designing future cannabis policies.